Medibank Discontinued Operations vs Ebit Analysis

MPL Stock

3.82 0.03 0.79%

Medibank Private financial indicator trend analysis is infinitely more than just investigating Medibank Private recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medibank Private is a good investment. Please check the relationship between Medibank Private Discontinued Operations and its Ebit accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Discontinued Operations vs Ebit

Discontinued Operations vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medibank Private Discontinued Operations account and Ebit. At this time, the significance of the direction appears to have no relationship.

The correlation between Medibank Private's Discontinued Operations and Ebit is 0.07. Overlapping area represents the amount of variation of Discontinued Operations that can explain the historical movement of Ebit in the same time period over historical financial statements of Medibank Private, assuming nothing else is changed. The correlation between historical values of Medibank Private's Discontinued Operations and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Discontinued Operations of Medibank Private are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Discontinued Operations i.e., Medibank Private's Discontinued Operations and Ebit go up and down completely randomly.

Correlation Coefficient

0.07

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Discontinued Operations

Ebit

Most indicators from Medibank Private's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medibank Private current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 911.2 M in 2025, whereas Tax Provision is likely to drop slightly above 186.5 M in 2025.

	2022	2023	2024	2025 (projected)
Operating Income	730.3M	7.1M	8.2M	7.8M
Total Revenue	7.5B	8.0B	9.2B	5.6B

Operating Income Total Revenue

Medibank Private fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Short Term Investments	Total Liab	Intangible Assets	Property Plant Equipment	Common Stock	Good Will	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Current Assets	Net Tangible Assets	Net Receivables
Total Assets		0.98	0.06	0.97	0.31	0.44	-0.26	0.12	0.57	0.39	0.32	-0.11	0.58	0.16	0.51	0.28	0.55	0.27	-0.76	0.06	-0.11	0.77	-0.67	0.61	0.83	-0.61
Total Stockholder Equity	0.98		0.02	1.0	0.29	0.42	-0.32	0.09	0.52	0.39	0.24	-0.14	0.6	0.15	0.4	0.29	0.53	0.3	-0.73	0.09	-0.14	0.79	-0.61	0.57	0.85	-0.62
Other Liab	0.06	0.02		0.0	0.16	0.51	-0.04	-0.1	-0.28	-0.19	0.25	-0.02	0.09	0.11	-0.3	0.06	-0.22	0.13	0.31	0.17	-0.02	-0.29	0.24	-0.14	-0.18	0.13
Retained Earnings	0.97	1.0	0.0		0.31	0.42	-0.27	0.15	0.52	0.44	0.23	-0.12	0.58	0.16	0.43	0.24	0.54	0.26	-0.74	0.05	-0.12	0.81	-0.61	0.56	0.85	-0.6
Accounts Payable	0.31	0.29	0.16	0.31		0.39	0.44	0.35	-0.34	0.61	0.73	0.22	-0.27	-0.33	0.01	-0.22	0.41	-0.41	-0.02	-0.55	0.22	0.11	0.16	-0.28	-0.06	0.22
Cash	0.44	0.42	0.51	0.42	0.39		-0.06	0.09	0.15	0.36	0.6	-0.01	0.35	-0.23	0.16	0.17	-0.24	0.12	-0.12	0.37	-0.01	0.15	-0.23	0.2	0.11	-0.2
Other Assets	-0.26	-0.32	-0.04	-0.27	0.44	-0.06		0.78	-0.55	0.49	0.18	0.74	-0.82	-0.09	0.13	-0.93	-0.04	-0.98	0.4	-0.6	0.74	-0.24	0.4	-0.69	-0.49	0.83
Short Term Investments	0.12	0.09	-0.1	0.15	0.35	0.09	0.78		-0.12	0.67	0.08	0.51	-0.41	0.09	0.46	-0.77	0.08	-0.73	0.01	-0.46	0.51	0.26	-0.01	-0.27	-0.01	0.46
Total Liab	0.57	0.52	-0.28	0.52	-0.34	0.15	-0.55	-0.12		0.12	0.0	-0.51	0.79	0.36	0.73	0.55	0.19	0.58	-0.77	0.35	-0.51	0.54	-0.93	0.94	0.71	-0.8
Intangible Assets	0.39	0.39	-0.19	0.44	0.61	0.36	0.49	0.67	0.12		0.5	0.19	-0.09	-0.06	0.45	-0.39	0.26	-0.48	-0.23	-0.44	0.19	0.33	-0.17	-0.04	0.1	0.14
Property Plant Equipment	0.32	0.24	0.25	0.23	0.73	0.6	0.18	0.08	0.0	0.5		0.07	-0.06	-0.27	0.18	0.14	0.15	-0.12	-0.06	-0.14	0.07	-0.04	-0.12	0.02	-0.11	0.02
Common Stock	-0.11	-0.14	-0.02	-0.12	0.22	-0.01	0.74	0.51	-0.51	0.19	0.07		-0.74	-0.09	-0.05	-0.77	-0.1	-0.78	0.39	-0.22	1.0	-0.22	0.36	-0.64	-0.39	0.69
Good Will	0.58	0.6	0.09	0.58	-0.27	0.35	-0.82	-0.41	0.79	-0.09	-0.06	-0.74		0.24	0.31	0.77	0.14	0.85	-0.67	0.49	-0.74	0.51	-0.71	0.89	0.73	-0.92
Other Current Liab	0.16	0.15	0.11	0.16	-0.33	-0.23	-0.09	0.09	0.36	-0.06	-0.27	-0.09	0.24		0.31	-0.01	0.17	0.15	-0.21	-0.05	-0.09	0.08	-0.35	0.32	0.32	-0.13
Total Current Liabilities	0.51	0.4	-0.3	0.43	0.01	0.16	0.13	0.46	0.73	0.45	0.18	-0.05	0.31	0.31		-0.03	0.3	-0.05	-0.69	-0.1	-0.05	0.54	-0.83	0.62	0.53	-0.36
Property Plant And Equipment Net	0.28	0.29	0.06	0.24	-0.22	0.17	-0.93	-0.77	0.55	-0.39	0.14	-0.77	0.77	-0.01	-0.03		0.11	0.94	-0.43	0.5	-0.77	0.21	-0.46	0.72	0.43	-0.83
Net Debt	0.55	0.53	-0.22	0.54	0.41	-0.24	-0.04	0.08	0.19	0.26	0.15	-0.1	0.14	0.17	0.3	0.11		0.02	-0.67	-0.65	-0.1	0.6	-0.37	0.29	0.55	-0.37
Non Current Assets Total	0.27	0.3	0.13	0.26	-0.41	0.12	-0.98	-0.73	0.58	-0.48	-0.12	-0.78	0.85	0.15	-0.05	0.94	0.02		-0.39	0.6	-0.78	0.21	-0.45	0.73	0.49	-0.82
Non Currrent Assets Other	-0.76	-0.73	0.31	-0.74	-0.02	-0.12	0.4	0.01	-0.77	-0.23	-0.06	0.39	-0.67	-0.21	-0.69	-0.43	-0.67	-0.39		0.06	0.39	-0.87	0.89	-0.83	-0.88	0.82
Cash And Short Term Investments	0.06	0.09	0.17	0.05	-0.55	0.37	-0.6	-0.46	0.35	-0.44	-0.14	-0.22	0.49	-0.05	-0.1	0.5	-0.65	0.6	0.06		-0.22	-0.07	-0.2	0.36	0.14	-0.37
Common Stock Shares Outstanding	-0.11	-0.14	-0.02	-0.12	0.22	-0.01	0.74	0.51	-0.51	0.19	0.07	1.0	-0.74	-0.09	-0.05	-0.77	-0.1	-0.78	0.39	-0.22		-0.22	0.36	-0.64	-0.39	0.69
Other Current Assets	0.77	0.79	-0.29	0.81	0.11	0.15	-0.24	0.26	0.54	0.33	-0.04	-0.22	0.51	0.08	0.54	0.21	0.6	0.21	-0.87	-0.07	-0.22		-0.68	0.62	0.88	-0.65
Other Stockholder Equity	-0.67	-0.61	0.24	-0.61	0.16	-0.23	0.4	-0.01	-0.93	-0.17	-0.12	0.36	-0.71	-0.35	-0.83	-0.46	-0.37	-0.45	0.89	-0.2	0.36	-0.68		-0.93	-0.79	0.79
Total Current Assets	0.61	0.57	-0.14	0.56	-0.28	0.2	-0.69	-0.27	0.94	-0.04	0.02	-0.64	0.89	0.32	0.62	0.72	0.29	0.73	-0.83	0.36	-0.64	0.62	-0.93		0.8	-0.93
Net Tangible Assets	0.83	0.85	-0.18	0.85	-0.06	0.11	-0.49	-0.01	0.71	0.1	-0.11	-0.39	0.73	0.32	0.53	0.43	0.55	0.49	-0.88	0.14	-0.39	0.88	-0.79	0.8		-0.8
Net Receivables	-0.61	-0.62	0.13	-0.6	0.22	-0.2	0.83	0.46	-0.8	0.14	0.02	0.69	-0.92	-0.13	-0.36	-0.83	-0.37	-0.82	0.82	-0.37	0.69	-0.65	0.79	-0.93	-0.8

Click cells to compare fundamentals

Medibank Private Account Relationship Matchups

Medibank Private fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	3.9B	4.6B	4.4B	4.7B	5.4B	3.1B
Total Stockholder Equity	1.9B	1.9B	2.1B	2.3B	2.7B	1.5B
Other Liab	117.7M	97.1M	120.5M	177.3M	203.9M	174.3M
Retained Earnings	1.8B	1.8B	2.0B	2.1B	2.4B	1.4B
Accounts Payable	239.9M	241.4M	215.7M	163.8M	188.4M	171.5M
Cash	671.7M	596.7M	420.6M	691M	621.9M	573.5M
Other Assets	2.7B	3.5B	3.5B	(6.9B)	(8.0B)	(7.6B)
Short Term Investments	2.3B	2.9B	2.9B	236.9M	272.4M	258.8M
Total Liab	2.0B	2.6B	2.3B	2.4B	2.7B	2.9B
Intangible Assets	345.3M	332.3M	328.1M	143.3M	164.8M	218.0M
Property Plant Equipment	112.2M	101.7M	88.4M	70.5M	81.1M	72.4M
Other Current Liab	(268M)	(388.6M)	1.3B	12.1M	13.9M	14.6M
Total Current Liabilities	1.0B	1.6B	1.3B	364.2M	418.8M	518.5M
Property Plant And Equipment Net	91.5M	78.4M	59.1M	205M	235.8M	247.5M
Net Debt	(578.3M)	(519.8M)	(365.3M)	(472.7M)	(543.6M)	(570.8M)
Non Current Assets Total	718.1M	876.2M	755.5M	6.9B	7.9B	8.3B
Non Currrent Assets Other	(2.4B)	(2.9B)	(3.0B)	(3.5B)	(3.2B)	(3.0B)
Cash And Short Term Investments	671.7M	596.7M	420.6M	927.9M	1.1B	702.2M
Liabilities And Stockholders Equity	3.9B	4.6B	4.4B	4.7B	5.4B	3.9B
Other Current Assets	3.2B	3.7B	3.4B	3.8B	4.3B	2.7B
Other Stockholder Equity	(1.8B)	(1.9B)	(1.9B)	(2.1B)	(1.9B)	(1.8B)
Total Current Assets	3.2B	3.7B	3.6B	4.7B	5.5B	5.7B
Accumulated Other Comprehensive Income	22.3M	25.7M	27.9M	152.3M	175.1M	183.9M
Net Tangible Assets	1.4B	1.6B	1.6B	1.8B	2.0B	1.6B
Net Receivables	215.9M	225.4M	248.1M	39.5M	35.6M	33.8M
Short Term Debt	28.1M	30.2M	30.9M	66.6M	59.9M	56.9M
Non Current Liabilities Total	978.3M	1.0B	997.2M	2.4B	2.7B	2.9B
Inventory	(887.6M)	(822.1M)	(668.7M)	(967.4M)	(1.1B)	(1.2B)
Long Term Investments	343.8M	338.3M	392.1M	295.6M	339.9M	334.5M
Long Term Debt Total	81.3M	65.3M	46.7M	24.4M	28.1M	34.2M
Net Invested Capital	1.9B	1.9B	2.1B	2.3B	2.7B	2.1B
Cash And Equivalents	871.4M	671.7M	596.7M	420.6M	378.5M	489.3M
Short Long Term Debt Total	93.4M	76.9M	55.3M	218.3M	251.0M	263.6M
Current Deferred Revenue	211.8M	117M	184.8M	48.7M	43.8M	41.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medibank Stock Analysis

When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC